Back to all news
HKU Develops AI-Enabled Optical Device for Rapid, Non-Invasive Cancer Risk Assessment
The University of Hong Kong has introduced a portable AI-enabled optical device for rapid, non-invasive cancer risk detection using saliva samples.
Key Details
- 1Device detects cancer risk through advanced chemical sensing and AI analysis of saliva samples.
- 2Detection process requires under 10 minutes and is designed for ease of use without medical personnel.
- 3Awarded a Gold Medal at the 51st International Exhibition of Inventions of Geneva (2026).
- 4Uses novel luminescent metal complexes that respond to DNA damage, signalling cancer-associated changes.
- 5Preliminary studies showed strong differentiation between healthy and cancer patients (breast and nasopharyngeal carcinoma).
- 6Large-scale clinical validations are underway in collaboration with multiple hospitals.
Why It Matters
This innovation represents a potential shift toward accessible, user-friendly cancer risk screening tools that leverage AI and advanced optical sensing, complementing traditional radiology and pathology workflows. Early, non-invasive detection could enhance monitoring, especially for high-risk populations, and advance integration between molecular diagnostics and digital health.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.